• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症中的抗精神病药物:益处与危害

Neuroleptic drugs in dementia: benefits and harm.

作者信息

Ballard Clive, Howard Robert

机构信息

Medical Research Council Centre for Neurodegeneration Research, King's College London, De Crespigny Park, London SE5 8AF, UK.

出版信息

Nat Rev Neurosci. 2006 Jun;7(6):492-500. doi: 10.1038/nrn1926.

DOI:10.1038/nrn1926
PMID:16715057
Abstract

Neuroleptic (antipsychotic) drugs are often used to treat psychiatric symptoms frequently seen in dementia, but their use is controversial. We present a new meta-analysis to assess the efficacy of these drugs for the treatment of psychiatric symptoms in Alzheimer's disease, and discuss the more limited evidence for their potential benefits in other dementias. We recommend that these treatments be limited to the short-term treatment of psychiatric symptoms associated with serious distress or risk.

摘要

抗精神病药物常用于治疗痴呆症中常见的精神症状,但其使用存在争议。我们进行了一项新的荟萃分析,以评估这些药物治疗阿尔茨海默病精神症状的疗效,并讨论其在其他痴呆症中潜在益处的更有限证据。我们建议,这些治疗应仅限于对伴有严重痛苦或风险的精神症状进行短期治疗。

相似文献

1
Neuroleptic drugs in dementia: benefits and harm.痴呆症中的抗精神病药物:益处与危害
Nat Rev Neurosci. 2006 Jun;7(6):492-500. doi: 10.1038/nrn1926.
2
Developing treatment guidelines for Alzheimer's disease and other dementias.制定阿尔茨海默病及其他痴呆症的治疗指南。
J Clin Psychiatry. 1996;57 Suppl 14:37-8.
3
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.利培酮治疗阿尔茨海默病和混合性痴呆所致精神病的疗效和安全性:4项安慰剂对照临床试验的荟萃分析。
Int J Geriatr Psychiatry. 2007 May;22(5):475-84. doi: 10.1002/gps.1792.
4
[Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].[痴呆症行为和心理症状的生物疗法:更新与展望]
Encephale. 2000 May-Jun;26(3):72-80.
5
Treatment of dementia: anything new?痴呆症的治疗:有什么新进展吗?
Curr Opin Psychiatry. 2006 Nov;19(6):575-80. doi: 10.1097/01.yco.0000245756.29244.b9.
6
Dementia and antipsychotic drugs.痴呆与抗精神病药物
J Clin Psychiatry. 1987 May;48 Suppl:16-8.
7
Current issues in dementia pharmacotherapy.痴呆症药物治疗的当前问题。
Am J Manag Care. 2007 Dec;13 Suppl 8:S198-202.
8
Agitation and psychosis in dementia.痴呆中的激越与精神病性症状
Am J Geriatr Psychiatry. 2007 Nov;15(11):913-7. doi: 10.1097/JGP.0b013e3181584268.
9
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.非典型抗精神病药物治疗痴呆的行为和心理症状,特别关注长期结局和死亡率。
Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5.
10
[Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].抗精神病药物用于治疗痴呆症患者的焦虑:是药物治疗还是化学约束?
Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1672-5.

引用本文的文献

1
Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease: Systematic review and meta-analysis.奥氮平和利培酮治疗阿尔茨海默病精神和行为症状的疗效和安全性比较:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Jul 5;103(27):e35663. doi: 10.1097/MD.0000000000035663.
2
Healthcare professionals' experiences with the use of antipsychotics in dementia.医疗保健专业人员使用抗精神病药物治疗痴呆症的经验。
Explor Res Clin Soc Pharm. 2024 Apr 21;14:100446. doi: 10.1016/j.rcsop.2024.100446. eCollection 2024 Jun.
3
Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A Review.
神经退行性疾病中神经精神综合征的药理学治疗进展:综述。
JAMA Neurol. 2024 Jun 1;81(6):645-653. doi: 10.1001/jamaneurol.2024.0586.
4
Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia.阿尔茨海默病、帕金森病和路易体痴呆患者未经纯化的脑脊液与脑脊液衍生细胞外囊泡的蛋白质组学比较。
J Extracell Vesicles. 2023 Dec;12(12):e12383. doi: 10.1002/jev2.12383.
5
Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.在血脑屏障中,氨磺必利与 GLUT1 的相互作用。与阿尔茨海默病的相关性。
PLoS One. 2023 Oct 24;18(10):e0286278. doi: 10.1371/journal.pone.0286278. eCollection 2023.
6
An investigation of psychoactive polypharmacy and related gender-differences in older adults with dementia: a retrospective cohort study.一项针对老年痴呆症患者精神活性药物联合使用情况及其相关性别差异的调查:一项回顾性队列研究。
BMC Geriatr. 2023 Oct 20;23(1):683. doi: 10.1186/s12877-023-04353-8.
7
Neurodegenerative Diseases: New Hopes and Perspectives.神经退行性疾病:新的希望和展望。
Curr Mol Med. 2024;24(8):1004-1032. doi: 10.2174/1566524023666230907093451.
8
Associations between early in-hospital medications and the development of delirium in patients with stroke.早期住院药物与中风患者谵妄发展的关系。
J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107249. doi: 10.1016/j.jstrokecerebrovasdis.2023.107249. Epub 2023 Aug 1.
9
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease.阿尔茨海默病铁淀粉样蛋白(FAB)大鼠模型中多巴胺系统功能异常。
Int J Mol Sci. 2023 Apr 13;24(8):7196. doi: 10.3390/ijms24087196.
10
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings.新冠疫情对疗养院中痴呆患者的神经精神症状和抗精神病药物处方的影响。
Int J Geriatr Psychiatry. 2023 Jan;38(1):e5878. doi: 10.1002/gps.5878.